Skip to content

Insomnia and Wake up and Recovery From Anesthesia

Insomnia and Wake up and Recovery From Anesthesia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04119531
Enrollment
80
Registered
2019-10-08
Start date
2017-12-04
Completion date
2021-01-30
Last updated
2021-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Keywords

anesthesia, recovery, insomnia

Brief summary

18-55 years old 100 patients, who are planned to undergo for planned ureteroscopy will be participated in the study. In the preoperative room patients will be asked to participate to the study. If they accept 4 item Jenkins-Sleep Questionaire will be asked to them.Patients will be divided to two groups , with or without insomnia according to their answers to the questionaire. General anesthesia will be performed to all patients. At the end of operation anesthesia time,operation time, time of eye opening, time of transfer to the recovery room will be recorded in the operating room. Pain scores and recovery scores will be evaluated in the recovery room.

Detailed description

18-55 years old 100 patients with American Society of Anesthesiology (ASA) physical status I-II,who are planned to undergo for elective ureteroscopy will be participated in this study.In the preoperative room patients will be asked to participate to the study and will be asked to answer the 4-item Jenkins-Sleep Questionaire.If they accept to participate, written informed consent will be taken from the patients. According to their answers to the questionaire , patients will be divided into two groups :those with or without insomnia.General anesthesia will be performed to all patients. After anesthesia induction with propofol 2mg/kg and rocuronium 0.6 mg/kg, patients will be ıntubated and mechanically ventilated. Maintenance of anesthesia will be achieved with 4-6 % desflurane in nitrous oxide/ oxygen (50%/50%) concentrations with the flow 5L/min. Tramadol 1 mg/kg and metoclopramid 1 ampul will be administered intravenously after intubation. Hemodynamic parameters( systolic blood pressure, diastolic blood pressure, heart rate and peripheral oxygen saturation), end tidal carbon dioxide values, the concentrations of inspired and exhaled desflurane will be recorded on the surgery start time and on the 5th, 15th,25th,35th,45th,60 th minutes of surgery. At the end of operation ,neuromuscular blockage will be reversed with neostigmine (0,05 mg/kg)and atropine sulphate 0,015 mg/kg i.v. Anesthesia time, surgery time, time of eye opening,time of transfer to the recovery room will be recorded in the operating room. In the recovery room pain score will be evaluated with Visual Analogue Scale. Modified Aldrete Recovery Score will be used for evaluating recovery.

Interventions

None listed

Sponsors

Adana City Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* 18- 55 years * ASA 1-2 patients * Patients undergoing elective ureteroscopy

Exclusion criteria

* Renal failure * Obstructive Sleep Apnea Syndrome, * Thyroid dysfunction * Neurologic and physiatric dysfunctions, * Morbid obesity * Anticonvulsant, antidepressant, anxiolytic drugs usage

Design outcomes

Primary

MeasureTime frameDescription
Time of eye openingup to 15 minutesfrom the time anesthesia was discontinued and neuromuscular blockage was reversed to the time of eye opening
Time of transpher to the postoperative care unitup to 25 minutesfrom the time anesthesia was discontinued and neuromuscular blockage was reversed to the time of transpher to the postoperative care unit
Recovery scoresduring 1 hour at postoperative periodModified Aldrete Recovery Score

Secondary

MeasureTime frameDescription
Pain scoresduring 1 hour at postoperative periodVisual analogue scale

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026